Bcg vaccine

1. Bcg vaccine lowers the risk of Parkinson's disease in humans (21.8% AAIR reduction at age 57, 4.4% at age 62).

   “In men, the age 12 policy showed a 21.8% AAIR reduction at age 57, which attenuated to 4.4% by age 62”

   Humansmales

   Long-Term Impact of Historical BCG Vaccination Policies on Parkinson's Disease Risk: A Hypothesis-Generating Retrospective Cohort Analysis · Biomedicines · 29 Aug 2026

Parkinson's disease →